Drugs / KT110
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06147622 | Apr → Jul 2024 | alcohol-related disorders | Kinnov Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KT110 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06147622 ↗ |
| Route | Oral | “Single Dose Oral Administration of KT110 Tablet” NCT06147622 ↗ |